Biopharmaceutical CMO and CRO Market By Service Type (Contract Manufacturing, Process Development, Downstream, Upstream, Fill & Finish Operations, Analytical & QC Studies, Packaging, Contract Research, Oncology, Inflammation & Immunology, Cardiology, Neuroscience, Others) By Source ( Mammalian, Non-mammalian) By Product (Biologics, Monoclonal antibodies (MAbs), Recombinant Proteins, Vaccines, Others, Biosimilars) By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033
- Published date: April 2024
- Report ID: 117975
- Number of Pages: 347
- Format:
-
-
-
- Boehringer Ingelheim GmbH
- Rentschler Biopharma SE
- JRS Pharma
- Biomeva GmbH
- Toyobo Co., Ltd.
- Samsung Biologics
- Thermo Fisher Scientific Company Profile
- WuXi Biologics
- AbbVie Inc. Company Profile
- Binex Co., Ltd.
- settingsSettings
Our Clients
✖
Request a Sample Report
We'll get back to you as quickly as possible
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
---|---|---|---|
e-Access | |||
Report Library Access | |||
Data Set (Excel) | |||
Company Profile Library Access | |||
Interactive Dashboard | |||
Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
Accessibility | 1 User | 2-5 User | Unlimited |
Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |